Fast Lane Only on MSN
The $3.5M Apollo EVO is back and almost as fast as a Corvette
The Apollo EVO has returned as a track-only spectacle, a $3.5 million sculpture of carbon and wings that chases lap times ...
CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical ...
A plan to slash drug review times at the Food and Drug Administration is sparking deep concerns among agency staffers and ...
The Daily Overview on MSN
White House fast-tracks debt cancellation for millions, see if you qualify
The White House is accelerating a new round of student debt cancellation, aiming to wipe out balances for millions of ...
According to a community announcement, the expansion is aimed at filling critical health care vacancies across Northern Michigan. More than $60,000 in scholarship support will be available in 2026, ...
South Korea’s plan to fast-track AI doctorates reflects a broader effort to strengthen its research competitiveness. Yet the initiative exposes a deeper structural problem — accelerating degrees ...
The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE: MRK) drugs with potential blockbuster sales. Merck's cholesterol treatment ...
On Wednesday, Trump unveiled the "Trump Gold Card" and "Trump Platinum Card," two contribution-based pathways marketed as offering unprecedented access to the United States. The Trump Gold Card offers ...
Dec 9 (Reuters) - The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application. The approval for the ...
FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly//File Photo Dec 9 (Reuters) - The U.S.
(RTTNews) - Cullinan Therapeutics, Inc. (CGEM) announced that the U.S. FDA has granted Fast Track Designation to CLN-049, a novel, investigational FLT3xCD3 bispecific T cell engager, for the treatment ...
As vicious infighting in President Donald Trump’s Make America Great Again movement over the controversial H-1B visa magnifies uncertainty for foreign workers in the U.S., Canada last week approved a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback